Anúncio
Anúncio

GH

GH logo

Guardant Health, Inc. Common Stock

112.34
USD
Patrocinado
+10.47
+10.28%
06 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

112.50

+0.16
+0.14%

Relatórios de Lucros GH

Rácio de surpresa positiva

GH separação 13 de 29 últimas estimativas.

45%

Próximo Relatório

Data do Próximo Relatório
18 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$275.85M
/
-$0.68
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+4.02%
/
-8.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+36.68%
/
-24.44%

Guardant Health, Inc. Common Stock earnings per share and revenue

On 29 de out. de 2025, GH reported earnings of -0.74 USD per share (EPS) for Q3 25, missing the estimate of -0.72 USD, resulting in a -2.27% surprise. Revenue reached 265.20 milhão, compared to an expected 242.76 milhão, with a 9.24% difference. The market reacted with a +27.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 analistas forecast an EPS of -0.68 USD, with revenue projected to reach 275.85 milhão USD, implying an diminuir of -8.11% EPS, and aumentar of 4.02% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, Guardant Health, Inc. Common Stock reported EPS of -$0.74, missing estimates by -2.27%, and revenue of $265.20M, 9.24% above expectations.
The stock price moved up 27.87%, changed from $72.27 before the earnings release to $92.41 the day after.
The next earning report is scheduled for 18 de fev. de 2026.
Based on 25 analistas, Guardant Health, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $275.85M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio